Doc.ai Blogs

by Chirag Patel, PhD and Arjun Manrai, PhD, scientific advisors to doc.aidoc.ai has seen awesome demand for a new kind of prospective research study called a data trial. Our first data trial was launched this past fall and called “Can Artificial Intelligence Predict Your Risk of Allergies?”The study…

by Walter De Brouwer, cofounder and CEO at doc.aiThere seems to be a consensus nowadays that medical information in the United States doubles every 73 days estimated to arrive at hefty 2.3 zettabytes (ZB) by 2020. But even these optimistic calculations do not take into account what happened this mon…

Medical data is a valuable asset and any asset that has value can be considered a currency. People who generate data should own that currency and be able to share, sell, buy, or do whatever else they choose to do with it. At doc.ai we give our users full ownership and control over their medical data…

Dec 10 2018Data scientists and machine learning engineers are the most in-demand professionals in the market to date. The downside of the growth of this community is the lack of ready-to-go infrastructure for easy and productive work. In order to address the needs of the community, especially resear…

You may never have heard the word “omics” before using the doc.ai app. However it might sound familiar because you probably already ran into the term “genomics”, the study of genomes. Our genes are part of the millions of biomarkers that make up our body and may be valuable in helping to predict our…